Insilico, which uses AI to accelerate drug discovery, says early data shows that rentosertib, a drug developed to treat a chronic lung disease, could slow aging (Cade Metz/New York Times)

Cade Metz / New York Times: Insilico, which uses AI to accelerate drug discovery, says early data shows that rentosertib, a drug developed to treat a chronic lung disease, could slow aging — Artificial intelligence was used to help develop a drug candidate, rentosertib, for a rare lung condition.